keyword
https://read.qxmd.com/read/38616273/sodium-bicarbonate-and-intubation-in-severe-diabetic-ketoacidosis-are-we-too-quick-to-dismiss-them
#1
JOURNAL ARTICLE
Manudi Vidanapathirana
Management of diabetic ketoacidosis (DKA) has internationally established guidelines. However, management of severe, refractory DKA with multiple contributors to acidosis, and management of DKA in patients with altered mentation, remain ambiguous. Use of sodium bicarbonate and intubation in DKA are unpopular treatment practices, but warrant consideration in these unique clinical scenarios. This paper describes a 61-year-old Sri Lankan female who presented with severe DKA, seizures and altered level of consciousness...
April 15, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38606848/evaluating-prescription-of-angiotensin-converting-enzyme-inhibitors-or-angiotensin-ii-receptor-blockers-in-patients-with-diabetes-and-albuminuria
#2
JOURNAL ARTICLE
Kittiphan Chienwichai, Phirada Chaloemwa, Sorawat Sangkaew, Arunchai Chang
AIM: Although guidelines recommend the use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II receptor blockers (ARB) in patients with diabetes, hypertension, and albuminuria, their use remains suboptimal in several developed countries. Limited data are available on ACEi/ARB use in developing countries. Here, we assessed the use of ACEi/ARB and identified factors contributing to their underutilization at Hatyai Hospital, Thailand. MATERIALS AND METHODS: This retrospective cross-sectional study was conducted using data from the Hatyai Hospital database...
April 12, 2024: Clinical Nephrology
https://read.qxmd.com/read/38567424/laboratory-changes-during-gender-affirming-hormone-therapy-in-transgender-adolescents
#3
JOURNAL ARTICLE
Kate Millington, Janet Y Lee, Johanna Olson-Kennedy, Robert Garofalo, Stephen M Rosenthal, Yee-Ming Chan
OBJECTIVES: Guidelines for monitoring of medications frequently used in the gender-affirming care of transgender and gender-diverse (TGD) adolescents are based on studies in adults or other medical conditions. In this study, we aimed to investigate commonly screened laboratory measurements in TGD adolescents receiving gender-affirming hormone therapy (GAHT). METHODS: TGD adolescents were recruited from 4 study sites in the United States before beginning GAHT. Hemoglobin, hematocrit, hemoglobin A1c, alanine transaminase, aspartate aminotransferase, prolactin, and potassium were abstracted from the medical record at baseline and at 6, 12, and 24 months after starting GAHT...
April 3, 2024: Pediatrics
https://read.qxmd.com/read/38557512/comparative-efficacy-and-safety-of-amlodipine-and-losartan-potassium-in-essential-hypertension-in-a-tertiary-hospital-of-bangladesh
#4
JOURNAL ARTICLE
R N Shimu, S Majumder, F Tarannum, D P Chowdhury, A Nahar, A Afrin, M Akter, S Nahar, S Jahan, M A Hossain
Hypertension is a common disorder of major clinical, public health and economic importance. It affects men and women of all ages, and the prevalence is increasing in most countries. Maintenance of blood pressure below 140/90 mm of Hg is recommended by most of the guideline available around the world. Various classes of drugs are being used in the treatment of hypertension. Losartan potassium and amlodipine are two different antihypertensive agents belonging to two different groups used commonly around the world in treating essential hypertension...
April 2024: Mymensingh Medical Journal: MMJ
https://read.qxmd.com/read/38511069/comparison-of-different-medical-treatments-for-primary-hyperaldosteronism-a-systematic-review-and-network-meta-analysis
#5
JOURNAL ARTICLE
Wen-Yu Ho, Ching-Chung Hsiao, Ping-Hsun Wu, Jui-Yi Chen, Yu-Kang Tu, Vin-Cent Wu, Jia-Jin Chen
BACKGROUND: The effectiveness and side effects between different medical treatments in patients with primary hyperaldosteronism have not been systematically studied. OBJECTIVE: To analyze the efficacy between different mineralocorticoid receptor antagonists (MRAs) and epithelial sodium channel (ENaC) inhibitors in a network meta-analysis (NMA) framework, while also evaluating adverse events. DESIGN: Systematic review and NMA. DATA SOURCES AND METHODS: The systematic review and NMA was reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines...
2024: Therapeutic Advances in Chronic Disease
https://read.qxmd.com/read/38508538/evaluation-of-effectiveness-hyperkalemia-and-hepatotoxicity-of-trimethoprim-sulfamethoxazole-prophylaxis-for-pneumocystis-jirovecii-pneumonia-in-pediatric-patients-a-single-center-retrospective-study
#6
JOURNAL ARTICLE
Hideo Kato, Mao Hagihara, Nobuhiro Asai, Hiroshige Mikamo, Takuya Iwamoto
BACKGROUND: American guidelines recommend trimethoprim-sulfamethoxazole (TMP-SMX) for preventing Pneumocystis jirovecii pneumonia (PJP) in pediatric patients at doses of 5-10 mg/kg/day of the TMP component, administered either daily, three times weekly, or twice weekly. However, limited studies describe the effectiveness and safety of these prophylactic regimens. Our study aimed to assess the clinical effectiveness and incidence of adverse events associated with each TMP-SMX regimen in pediatric patients, and to identify risk factors for adverse events...
March 18, 2024: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/38453264/hyperkalemia-and-plant-based-diets-in-chronic-kidney-disease
#7
REVIEW
John Sebastian Babich, Léonie Dupuis, Kamyar Kalantar-Zadeh, Shivam Joshi
Traditional dietary guidelines for patients with kidney disease recommend restriction of plant foods due to concerns about hyperkalemia and associated adverse events. Studies conducted over several decades have shown that the basis for these guidelines does not match the evidence. Serum potassium levels can be elevated in patients with reduced kidney function after consumption of foods with potassium-based additives or with highly concentrated potassium content such as juices, dried fruit, or purees. However, plant foods may have certain qualities that may blunt potassium retention including their alkalinizing effects, the lack of bioavailable potassium, and the impact of dietary fiber in organic plant foods on colonic potassium excretion...
November 2023: Adv Kidney Dis Health
https://read.qxmd.com/read/38448689/managing-hyperkalemia-in-patients-with-heart-failure-on-guideline-directed-medical-therapy-challenges-and-opportunities
#8
JOURNAL ARTICLE
Giorgio Gentile, Jahid Hossain, Erberto Carluccio, Gianpaolo Reboldi
Heart failure is a chronic and invalidating syndrome that affects tens of millions of people worldwide with significant socio-economic ramifications for the health care systems. Significant progress in the understanding of the pathophysiology of heart failure has allowed the gradual introduction of several drug classes for the management of such patients. Beta-blockers, mineralocorticoid receptor antagonists, angiotensin receptor neprilysin inhibitors, and sodium-glucose-cotransporter 2 inhibitors are all considered pillars of the guideline-directed medical therapy for heart failure...
March 7, 2024: Internal and Emergency Medicine
https://read.qxmd.com/read/38319948/inferring-personal-intake-recommendations-of-phosphorous-and-potassium-for-end-stage-renal-failure-patients-by-simulating-with-bayesian-hierarchical-multivariate-model
#9
JOURNAL ARTICLE
Jari Turkia, Ursula Schwab, Ville Hautamäki
Most end-stage renal disease (ESRD) patients face a risk of malnutrition, partly due to dietary restrictions on phosphorous and, in some cases, potassium intake. These restrictions aim to regulate plasma phosphate and potassium concentrations and prevent the adverse effects of hyperphosphatemia or hyperkalemia. However, individual responses to nutrition are known to vary, highlighting the need for personalized recommendations rather than relying solely on general guidelines. In this study, our objective was to develop a Bayesian hierarchical multivariate model that estimates the individual effects of nutrients on plasma concentrations and to present a recommendation algorithm that utilizes this model to infer personalized dietary intakes capable of achieving normal ranges for all considered concentrations...
2024: PloS One
https://read.qxmd.com/read/38284271/potassium-enriched-salt-substitutes-a-review-of-recommendations-in-clinical-management-guidelines
#10
REVIEW
Xiaoyue Xu, Ling Zeng, Vivekanand Jha, Laura K Cobb, Kenji Shibuya, Lawrence J Appel, Bruce Neal, Aletta E Schutte
Excess dietary sodium intake and insufficient dietary potassium intake are both well-established risk factors for hypertension. Despite some successful initiatives, efforts to control hypertension by improving dietary intake have largely failed because the changes required are mostly too hard to implement. Consistent recent data from randomized controlled trials show that potassium-enriched, sodium-reduced salt substitutes are an effective option for improving consumption levels and reducing blood pressure and the rates of cardiovascular events and deaths...
January 29, 2024: Hypertension
https://read.qxmd.com/read/38233719/a-balancing-act-drifting-away-from-the-reflexive-use-of-ab-normal-saline
#11
JOURNAL ARTICLE
Linda Wang, Celeste Dixon, Jennifer Nhan, Aadil Kakajiwala
Maintenance intravenous fluids are the most frequently ordered medications for hospitalized children. Since the American Association of Pediatrics published national guidelines, there has been an increased reflexive use of isotonic solutions, especially 0.9% saline, as a prophylaxis against hyponatremia. In this educational review, we discuss the potential deleterious effects of using 0.9% saline, including the development of hyperchloremia, metabolic acidosis, acute kidney injury, hyperkalemia, and a proinflammatory state...
January 18, 2024: Pediatric Nephrology
https://read.qxmd.com/read/38117963/comparison-of-class-specific-side-effects-across-preventative-pharmacologic-therapies-for-kidney-stone-disease
#12
JOURNAL ARTICLE
Ryan S Hsi, Joseph J Crivelli, Phyllis L Yan, Vahakn Shahinian, John M Hollingsworth
INTRODUCTION: Clinical guidelines recommend monitoring for metabolic derangements while on preventive pharmacologic therapy for kidney stone disease. The study objective was to compare the frequency of side effects among patients receiving alkali citrate, thiazides, and allopurinol. METHODS: Using claims data from working-age adults with kidney stone disease (2008-2019), we identified those with a new prescription for alkali citrate, thiazide, or allopurinol within 12 months after their index stone-related diagnosis or procedure...
January 2024: Urology Practice
https://read.qxmd.com/read/38101515/a-population-based-cohort-defined-risk-of-hyperkalemia-after-initiating-sglt-2-inhibitors-glp1-receptor-agonists-or-dpp-4-inhibitors-to-patients-with-chronic-kidney-disease-and-type-2-diabetes
#13
JOURNAL ARTICLE
Edouard L Fu, Julianna Mastrorilli, Katsiaryna Bykov, Deborah J Wexler, Alexander Cervone, Kueiyu Joshua Lin, Elisabetta Patorno, Julie M Paik
Hyperkalemia is a common adverse event in patients with chronic kidney disease (CKD) and type 2 diabetes and limits the use of guideline-recommended therapies such as renin-angiotensin system inhibitors. Here, we evaluated the comparative effects of sodium-glucose cotransporter-2 inhibitors (SGLT-2i), glucagon-like peptide-1 receptor agonists (GLP-1RA) and dipeptidyl peptidase-4 inhibitors (DPP-4i) on the risk of hyperkalemia. We conducted a population-based active-comparator, new-user cohort study using claims data from Medicare and two large United States commercial insurance databases (April 2013-April 2022)...
March 2024: Kidney International
https://read.qxmd.com/read/37967978/financial-implication-of-sodium-zirconium-cyclosilicate-therapy-in-patients-with-systolic-heart-failure-and-hyperkalemia
#14
JOURNAL ARTICLE
Teruhiko Imamura, Nikhil Narang, Koichiro Kinugawa
Sodium zirconium cyclosilicate (SZC), a newly-introduced potassium binder, can be used to manage hyperkalemia especially in patients with chronic kidney disease and in those on medical therapy which may raise serum potassium levels. The medication may incur additional costs but may in turn have a significant benefit in the effect of maintaining guideline-directed medical therapy for heart failure. We aimed to investigate the financial impact of SZC therapy in patients with systolic heart failure.Patients with systolic heart failure who received SZC for hyperkalemia between July 2020 and March 2023 were included...
November 14, 2023: International Heart Journal
https://read.qxmd.com/read/37943221/rationale-design-and-patient-characteristics-of-a-cluster-randomized-pragmatic-trial-to-improve-mineralocorticoid-antagonist-use
#15
JOURNAL ARTICLE
Katherine A A Clark, Angela M Victoria-Castro, Lama Ghazi, Yu Yamamoto, Claudia Coronel-Moreno, Bashar Adel Kadhim, Ralph J Riello, Kyle O'Connor, Tariq Ahmad, F Perry Wilson, Nihar R Desai
BACKGROUND: Despite robust evidence and strong guideline recommendations supporting use of mineralocorticoid receptor antagonists (MRAs) to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF), these medications remain underused in clinical practice. OBJECTIVES: The goal is to determine if providing a tailored best practice alert (BPA) to outpatient providers suggesting guideline-recommended MRAs or information about available hyperkalemia treatment, if present, for patients with HFrEF will increase short-term MRA prescriptions...
October 26, 2023: JACC. Heart Failure
https://read.qxmd.com/read/37921685/sodium-bicarbonate-and-calcium-chloride-for-the-treatment-of-hyperkalemia-induced-cardiac-arrest-a-randomized-blinded-placebo-controlled-animal-study
#16
JOURNAL ARTICLE
Mark Andreas Eggertsen, Cecilie Munch Johannsen, Alexander Kovacevic, Mikael Fink Vallentin, Lauge Mørk Vammen, Lars W Andersen, Asger Granfeldt
OBJECTIVES: Current international guidelines recommend administrating calcium chloride and sodium bicarbonate to patients with hyperkalemia-induced cardiac arrest, despite limited evidence. The aim of this study was to evaluate the efficacy of calcium chloride and sodium bicarbonate on return of spontaneous circulation (ROSC) in a pig model of hyperkalemia-induced cardiac arrest. DESIGN: A randomized, blinded, placebo-controlled experimental pig study. Hyperkalemia was induced by continuous infusion of potassium chloride over 45 minutes followed by a bolus...
February 1, 2024: Critical Care Medicine
https://read.qxmd.com/read/37892815/electrolyte-disturbances-related-to-sodium-and-potassium-and-electroconvulsive-therapy-a-systematic-review
#17
REVIEW
Adam Gędek, Michał Materna, Paweł Majewski, Anna Z Antosik, Monika Dominiak
INTRODUCTION: Electrolyte disturbances related to sodium and potassium affect patients with mental disorders undergoing electroconvulsive therapy (ECT). The objective of this study was to systematically summarize the data regarding ECT and electrolyte disturbances related to sodium and potassium. MATERIALS AND METHODS: A systematic literature review in accordance with PRISMA guidelines was conducted. Clinical studies of patients receiving ECT with electrolyte disturbances reported before or after treatment were included...
October 22, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37842482/a-case-of-prolonged-recovery-for-post-percutaneous-coronary-intervention-pci-sodium-glucose-cotransporter-2-sglt2-inhibitor-induced-euglycemic-diabetic-ketoacidosis-in-a-28-year-old
#18
Cyrena Petersen, Frederick Gyabaah, Jose Sotelo, Sandeesh Yohanna, Abhizith Deoker
Euglycemic diabetic ketoacidosis (DKA) is a rare, but clinically important, presentation that can lead to significant morbidity and mortality in patients with diabetes mellitus. It has been associated with multiple etiologies, including sodium-glucose cotransport-2 (SGLT2) inhibitor use. This case report details the presentation of a 28-year-old male patient who was recently diagnosed with non-ST elevated myocardial infarction (NSTEMI) status post-percutaneous coronary intervention (PCI) to left anterior descending (LAD) and type 2 diabetes mellitus (T2DM) and discharged on a new medical regiment that included an SGLT2 inhibitor...
September 2023: Curēus
https://read.qxmd.com/read/37820896/safety-indicators-in-patients-receiving-high-intensity-care-after-hospital-admission-for-acute-heart-failure-the-strong-hf-trial
#19
JOURNAL ARTICLE
Daniela Tomasoni, Beth Davison, Marianna Adamo, Matteo Pagnesi, Alexandre Mebazaa, Christopher Edwards, Mattia Arrigo, Marianela Barros, Jan Biegus, Jelena Čelutkienė, Kamilė Čerlinskaitė-Bajorė, Ovidiu Chioncel, Alain Cohen-Solal, Albertino Damasceno, Rafael Diaz, Gerasimos Filippatos, Etienne Gayat, Antoine Kimmoun, Carolyn S P Lam, Maria Novosadova, Peter S Pang, Piotr Ponikowski, Hadiza Saidu, Karen Sliwa, Koji Takagi, Jozine M Ter Maaten, Adriaan Voors, Gad Cotter, Marco Metra
BACKGROUND: STRONG-HF demonstrated the safety and efficacy of rapid up-titration of guideline-directed medical therapy (GDMT) with high intensity care (HIC) compared to usual care in patients hospitalized for acute heart failure (HF). In the HIC group, the following safety indicators were used to guide up-titration: estimated glomerular filtration rate [eGFR] <30ml/min/1.73m2 , serum potassium >5.0 mmol/L, systolic blood pressure (SBP) <95mmHg, heart rate <55bpm, NT-proBNP concentration >10% higher than pre-discharge values...
September 29, 2023: Journal of Cardiac Failure
https://read.qxmd.com/read/37811017/efficacy-and-safety-of-finerenone-in-chronic-kidney-disease-and-type-2-diabetes-patients-a-systematic-review-and-meta-analysis
#20
REVIEW
Farah Yasmin, Muhammad Aamir, Hala Najeeb, Abdul Raafe Atif, Abdul Hannan Siddiqui, Muhammad Nadeem Ahsan, Abdul Moeed, Syed Hasan Ali, Haya Muhammad Tahir, Muhammad Sohaib Asghar
BACKGROUND AND OBJECTIVES: The incidence of morbidity and mortality in patients with type 2 diabetes mellitus is substantially correlated with cardiovascular disease and chronic kidney disease. The current guidelines recommend the use of renin-angiotensin system blockers, but recent studies probed into the effects of finerenone to mitigate the risk of cardiorenal events. This meta-analysis was performed to demonstrate the effects of finerenone on cardiorenal events, comprising cardiovascular mortality, heart failure, change in estimated glomerular filtration rate, and serum potassium levels...
October 2023: Annals of Medicine and Surgery
keyword
keyword
119355
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.